Hilal Maradit Kremers1, Dirk R Larson2, Mohamed Noureldin3, Cathy D Schleck2, William A Jiranek4, Daniel J Berry3. 1. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota; Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota. 2. Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota. 3. Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota. 4. Department of Orthopedic Surgery, Virginia Commonwealth University (VCU) Medical Center, Richmond, Virginia.
Abstract
BACKGROUND: Mortality after total hip and knee arthroplasty is lower than that in the general population, but it is unknown whether there are differences by surgery type, demographics, and calendar year. Our objective was to evaluate trends and determinants of long-term mortality among patients with total hip and knee arthroplasties. METHODS: Using a historical cohort study design, we passively followed up population-based cohorts of total hip and total knee arthroplasty patients with degenerative arthritis who underwent surgery between January 1, 1969 and December 31, 2008. Patients were followed up until death or August 31, 2014. Observed and expected survival was compared using standardized mortality ratios (SMRs). Poisson regression models were used to examine relative mortality patterns by surgery type, age, sex, calendar year, and time since surgery. RESULTS: The overall age- and sex-adjusted mortality was significantly lower than that in the general population after both total hip (SMR: 0.82, 95% CI: 0.76-0.88) and total knee (SMR = 0.80, 95% CI: 0.75-0.86) arthroplasties. Despite the low relative mortality within the first 8 years of surgery, we observed a worsening of relative mortality beyond 15 years after total knee arthroplasty surgery. Both short- and long-term mortality improved over calendar time, and the improvement occurred about a decade earlier in total knee arthroplasty than in total hip arthroplasty. CONCLUSION: Survival after total hip and total knee arthroplasties is better than that in the general population for about 8 years after surgery. Secular trends are encouraging and suggest that survival after both procedures has been improving even further in recent years.
BACKGROUND: Mortality after total hip and knee arthroplasty is lower than that in the general population, but it is unknown whether there are differences by surgery type, demographics, and calendar year. Our objective was to evaluate trends and determinants of long-term mortality among patients with total hip and knee arthroplasties. METHODS: Using a historical cohort study design, we passively followed up population-based cohorts of total hip and total knee arthroplastypatients with degenerative arthritis who underwent surgery between January 1, 1969 and December 31, 2008. Patients were followed up until death or August 31, 2014. Observed and expected survival was compared using standardized mortality ratios (SMRs). Poisson regression models were used to examine relative mortality patterns by surgery type, age, sex, calendar year, and time since surgery. RESULTS: The overall age- and sex-adjusted mortality was significantly lower than that in the general population after both total hip (SMR: 0.82, 95% CI: 0.76-0.88) and total knee (SMR = 0.80, 95% CI: 0.75-0.86) arthroplasties. Despite the low relative mortality within the first 8 years of surgery, we observed a worsening of relative mortality beyond 15 years after total knee arthroplasty surgery. Both short- and long-term mortality improved over calendar time, and the improvement occurred about a decade earlier in total knee arthroplasty than in total hip arthroplasty. CONCLUSION: Survival after total hip and total knee arthroplasties is better than that in the general population for about 8 years after surgery. Secular trends are encouraging and suggest that survival after both procedures has been improving even further in recent years.
Authors: Jane Barrett; Elena Losina; John A Baron; Nizar N Mahomed; John Wright; Jeffrey N Katz Journal: J Bone Joint Surg Am Date: 2005-09 Impact factor: 5.284
Authors: Linda P Hunt; Yoav Ben-Shlomo; Emma M Clark; Paul Dieppe; Andrew Judge; Alex J MacGregor; Jon H Tobias; Kelly Vernon; Ashley W Blom Journal: Lancet Date: 2013-09-28 Impact factor: 79.321
Authors: Hilal Maradit Kremers; Dirk R Larson; Cynthia S Crowson; Walter K Kremers; Raynard E Washington; Claudia A Steiner; William A Jiranek; Daniel J Berry Journal: J Bone Joint Surg Am Date: 2015-09-02 Impact factor: 5.284
Authors: Linda P Hunt; Yoav Ben-Shlomo; Emma M Clark; Paul Dieppe; Andrew Judge; Alex J MacGregor; Jon H Tobias; Kelly Vernon; Ashley W Blom Journal: Lancet Date: 2014-10-18 Impact factor: 79.321
Authors: Arief Lalmohamed; Peter Vestergaard; Anthonius de Boer; Hubertus G M Leufkens; Tjeerd P van Staa; Frank de Vries Journal: Arthritis Rheumatol Date: 2014-02 Impact factor: 10.995
Authors: Bheeshma Ravi; Ruth Croxford; Peter C Austin; Lorraine Lipscombe; Arlene S Bierman; Paula J Harvey; Gillian A Hawker Journal: BMJ Date: 2013-10-30
Authors: Ian A Harris; Alesha Hatton; Nicole Pratt; Michelle Lorimer; Justine M Naylor; Richard de Steiger; Peter Lewis; Stephen E Graves Journal: Clin Orthop Relat Res Date: 2019-06 Impact factor: 4.176
Authors: Jie J Yao; Hilal Maradit Kremers; Matthew P Abdel; Dirk R Larson; Jeanine E Ransom; Daniel J Berry; David G Lewallen Journal: Clin Orthop Relat Res Date: 2018-02 Impact factor: 4.176
Authors: Peter Cnudde; Ola Rolfson; A John Timperley; Anne Garland; Johan Kärrholm; Göran Garellick; Szilard Nemes Journal: Clin Orthop Relat Res Date: 2018-06 Impact factor: 4.176
Authors: Peter Cnudde; Szilard Nemes; Maziar Mohaddes; John Timperley; Göran Garellick; Kristina Burström; Ola Rolfson Journal: Int J Environ Res Public Health Date: 2017-08-10 Impact factor: 3.390
Authors: Courtney E Baker; Brian P Chalmers; Michael J Taunton; Hilal Maradit Kremers; Adam W Amundson; Daniel J Berry; Matthew P Abdel Journal: J Arthroplasty Date: 2021-07-16 Impact factor: 4.435